The case for adopting Senza spinal cord stimulation (SCS) for delivering HF10 therapy as a treatment option for chronic neuropathic back or leg pain after failed back surgery is supported by the ...

Primary results from a randomized (1:1), open-label phase II study of talimogene laherparepvec (T) and ipilimumab (I) vs I alone in unresected stage IIIB- IV melanoma. This is an ASCO Meeting Abstract ...

CHICAGO, July 28 (UPI) --High-frequency spinal cord stimulation had nearly twice the effectiveness for chronic back and leg pain patients as traditional low frequency stimulation in a recent study.

Patients who experience severe chronic pain in the back and legs could have a new treatment, according to a study published in the November issue of Neurosurgery. The new technique assures lasting ...

Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who have received PD-1 based therapy. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract ...

For patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, ...

Patients who received a novel high frequency form of spinal cord stimulation (SCS) therapy experienced significantly greater, long-term relief for both chronic back and leg pain, when compared to a ...

Chronic back pain is a stubborn problem for many Americans, but technology is opening the door to a new drug-free form of treatment at Sutter Health’s surgery center in Santa Rosa. Chronic back pain ...